-
Many clinicians are reluctant to give low-dose aspirin (ldasa) to pregnant women for the prevention of preeclampsia. This reluctance is not based on a fear of potential risk, but on inconsistent study results regarding the efficacy of ASA.
-
Secondary recurrent miscarriage (defined as three or more pregnancy losses at < 20 weeks occurring in a women with a least one pregnancy carried beyond 20 weeks) may be explained by a chromosomal abnormality or be "unexplained" (idiopathic).
-
The "Caprisa 004" trial was a randomized double-blind controlled trial of 1085 sexually active, HIV-negative, high-risk women in South Africa over 2.5 years (889 women were included in the final analysis).
-
-
-
Previous investigation of cervical cancer biology has revealed a dependence on VEGF, among other factors, for growth and metastases.
-
The author summarizes the protocols used at his institution to prevent adhesions in patients who were undergoing evaluation and treatment for significant pelvic pathology.
-
In this issue: Antiviral drugs and birth defects, bisphosphonates and esophageal cancer, naltrexone plus bupropion for weight loss, 2010-11 influenza vaccine, FDA Actions.
-
Before patients are admitted to Intermountain McKay-Dee Hospital, a patient flow nurse completes the first level of review for medical necessity and works with the admitting physician to determine the patient status.
-
With its approach to glycemic control, SMS St. Mary's Health Center in St. Louis, aims to shorten lengths of stay and "break the cycle of the revolving hospital door," for patients with diabetes as a primary or secondary condition, says Philip Vaidyan, MD, head of the IPC academic hospitalist program.
